Contineum Therapeutics (CTNM) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.40
- Estimate
- -$0.45
- Surprise
- +10.8%
- Score today
- 5.3/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Contineum Therapeutics (CTNM) reported a narrower loss than forecast — adjusted EPS of -$0.40 against the -$0.45 estimate (a 10.8% beat on a still-unprofitable quarter).
Where TrendMatrix's rating stands now
TrendMatrix currently rates CTNM Hold at 5.3/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's +10.8% surprise compares with a +0.8% four-quarter average. Next scheduled report: 2027-03-04.
What argues against it
- Concentration risk — Pipeline: PIPE-791
- Market cap $387M below $400M minimum
- Value-trap signals (3/5): Revenue declining (-42.9% YoY), Margin compression (op margin -5577.0%), Negative free cash flow
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $9.67
- Price target
- $18.64
- Stop
- $8.99
- Upside to target
- +92.8%
- Reward-to-risk
- 6.2:1
Model outputs from TrendMatrix’s engine as of 2026-11-17 — shown for context, not personalized investment advice.
CTNM at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Biotechnology
- Market cap
- $387.2M
- P/E (fwd)
- -4.8
- 52-week range
- $6.72–$17.79
- Off 52-week high
- 45.6%
- RSI (14)
- 57
- Volume vs avg
- 0.62×
- Score today
- 5.3/10